Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
145.93B
Market cap145.93B
Price-Earnings ratio
45.81
Price-Earnings ratio45.81
Dividend yield
0.88%
Dividend yield0.88%
Average volume
2.12M
Average volume2.12M
High today
$385.96
High today$385.96
Low today
$379.25
Low today$379.25
Open price
$384.05
Open price$384.05
Volume
1.25M
Volume1.25M
52 Week high
$404.87
52 Week high$404.87
52 Week low
$329.16
52 Week low$329.16

Stock Snapshot

With a market cap of 145.93B, Stryker(SYK) trades at $381.33. The stock has a price-to-earnings ratio of 45.81 and currently yields dividends of 88.4%.

During the trading session on 2026-02-24, Stryker(SYK) shares reached a daily high of $385.96 and a low of $379.25. At a current price of $381.33, the stock is +0.5% higher than the low and still -1.2% under the high.

Trading activity shows a volume of 1.25M, compared to an average daily volume of 2.12M.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

SYK News

TipRanks 8h
Stryker price target raised to $400 from $386 at UBS

UBS raised the firm’s price target on Stryker (SYK) to $400 from $386 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source...

Simply Wall St 20h
Assessing Stryker Valuation After Launch Of T2 Alpha Humerus Nailing System

Advertisement Why Stryker’s new T2 Alpha Humerus Nailing System matters for shareholders Stryker (SYK) has rolled out its T2 Alpha Humerus Nailing System, a p...

Assessing Stryker Valuation After Launch Of T2 Alpha Humerus Nailing System

Analyst ratings

79%

of 33 ratings
Buy
78.8%
Hold
18.2%
Sell
3%

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.